Ryufin

Relx PLC

Netherlands · GB00B2B0DG97 · reports in GBP · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?Fair
Revenue +1.7% in the year to Dec 31, 2025, on the year before.
Is it a good business?Good
It earned 87% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?To watch
Equity is 16% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in GBP.

£9.6B

revenue

32%

operating margin

£2.1B

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue£8.6B£9.2B£9.4B£9.6B
Operating profit£2.3B£2.7B£2.9B£3.0B
Net profit to shareholders£1.6B£1.8B£1.9B£2.1B
Earnings per share£0.85£0.94£1.04£1.13
Cash from operations£2.4B£2.5B£2.6B£2.8B
Capital spending£36M£30M£20M£21M
Cash£334M£155M£119M£131M
Total assets£15.8Bn/a£15.1B£14.8B
Equity£3.8B£3.4B£3.5B£2.4B

What they do

In the company's own words, from the annual report.

RELX is a global provider of information-based analytics and decision tools for professional and business customers, enabling them to make better decisions, get better results and be more productive. Our purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve justice and fair results for their clients; businesses and governments prevent fraud; consumers access financial services and get fair prices on insurance; and customers learn about markets and complete transactions.

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.